Vaccines, Blood & Biologics
Measles, Mumps and Rubella Virus Vaccine, Live
STN: BL 101069
Proper Name: Measles, Mumps, and Rubella Virus Vaccine, Live
Tradename: M-M-R II
Manufacturer: Merck & Co., Inc, License #0002
- M-M-R II is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.
April 25, 2014 Approval Letter - MMR II
To add the term ADEM (acute disseminated encephalomyelitits) to the Adverse Reactions section of the US Prescribing Information (USPI).
January 30, 2014 Approval Letter - MMR II
To include the addition of a 2-Dimensional (2D) barcode to the MMR II® vaccine vial label, has been date stamped and issued.
May 16, 2008 Approval Letter - Measles, Mumps, and Rubella Virus Vaccine, Live
Package Insert Changes: To include epididymitis under Urogenital System in the adverse reactions section of the package insert to reflect reports received during post-marketing surveillance, and to include additional minor editorial changes.